Find your next M&A target
Target Asia + Worldwide M&A projects with our guidance on matching, planning, due diligence & implementation.
Israeli biomedical company has a IVF project and seeks investment.
|Total value of the target||N/A|
|Expected target net rate of return after deducting all taxes and fees||N/A|
|Validity period of pending order||365|
Assistant Manager, International Business Advisory
|Project highlights||IVF treatment - proprietary technology - clinical trial phase|
The Israeli biomedicine company’s project improves the success rate of IVF treatment based on its proprietary technology, which determines the patient's uterine preparation through continuous real-time monitoring in vivo. This personalized medical solution provides direct information about the condition of the endometrium. At present, it has raised 1.5 million US dollars, which is mainly used to continue clinical trials and expand its intellectual property rights and complete prototype design. It is planned to submit documents for registration within one and a half years upon which the business will start.
Enquire for more information about our services, and how we can help solve challenges for your organizationContact Us